1. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet (London, England). 2019;393(10167):169 − 82.
2. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global health. 2020;8(2):e191-e203.
3. Mac M, Moody CA. Epigenetic Regulation of the Human Papillomavirus Life Cycle. Pathogens (Basel, Switzerland). 2020;9(6).
4. Vinson C, Acharya A, Taparowsky EJ. Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochimica et biophysica acta. 2006;1759(1–2):4–12.
5. Katsuoka F, Yamamoto M. Small Maf proteins (MafF, MafG, MafK): History, structure and function. Gene. 2016;586(2):197–205.
6. Kannan MB, Solovieva V, Blank V. The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives. Biochimica et biophysica acta. 2012;1823(10):1841-6.
7. Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, et al. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer biology & therapy. 2007;6(10):1592-9.
8. Balkhi MY, Trivedi AK, Geletu M, Christopeit M, Bohlander SK, Behre HM, et al. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene. 2006;25(53):7041-58.
9. Okita Y, Kimura M, Xie R, Chen C, Shen LT, Kojima Y, et al. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB. Science signaling. 2017;10(474).
10. Wang R, Zheng J, Zhang DS, Yang YH, Zhao ZF. Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation. Genetics and molecular research : GMR. 2015;14(3):7315-25.
11. Aydin C, Kalkan R. Cancer Treatment: An Epigenetic View. Global medical genetics. 2020;7(1):3–7.
12. Kraboth Z, Galik B, Tompa M, Kajtar B, Urban P, Gyenesei A, et al. DNA CpG methylation in sequential glioblastoma specimens. Journal of cancer research and clinical oncology. 2020;146(11):2885-96.
13. Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes. 2020;11(8).
14. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell. 2013;153(1):38–55.
15. Wang Z, Li Z, Wu Q, Li C, Li J, Zhang Y, et al. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer. Cell death & disease. 2020;11(8):642.
16. Ma C, Xu B, Husaiyin S, Wang L, Wusainahong K, Ma J, et al. MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017;92:586 − 94.
17. Peng L, Hu Y, Chen D, Linghu R, Wang Y, Kou X, et al. Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway. Oncology letters. 2016;12(6):4531-7.
18. Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014;35(5):1039-45.
19. Wu X, Peng L, Zhang Y, Chen S, Lei Q, Li G, et al. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis. International journal of medical sciences. 2019;16(6):800 − 12.
20. Liu R, Shuai Y, Luo J, Zhang Z. SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis. Frontiers in oncology. 2019;9:1035.
21. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457 − 63.
22. Goluboff ET. Exisulind, a selective apoptotic antineoplastic drug. Expert opinion on investigational drugs. 2001;10(10):1875-82.
23. Chan DC, Earle KA, Zhao TL, Helfrich B, Zeng C, Baron A, et al. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res. 2002;8(3):904 − 12.
24. Li K, Fan J, Qin X, Wei Q. Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database. Medicine. 2020;99(51):e23768.
25. Liu J, Feng M, Li S, Nie S, Wang H, Wu S, et al. Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study. Cancer cell international. 2020;20:59.